These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 450208)
1. Dopamine-beta-hydroxylase and norepinephrine in human cerebrospinal fluid: effects of monoamine oxidase inhibitors. Lerner P; Major LF; Murphy DL; Lipper S; Lake CR; Lovenberg W Neuropharmacology; 1979 Apr; 18(4):423-6. PubMed ID: 450208 [No Abstract] [Full Text] [Related]
2. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain. Nguyen TB; Angers M Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430 [TBL] [Abstract][Full Text] [Related]
3. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications. Fowler CJ; Oreland L; Callingham BA J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003 [No Abstract] [Full Text] [Related]
4. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors. Juorio AV; Greenshaw AJ; Wishart TB Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):644-8. PubMed ID: 3149722 [TBL] [Abstract][Full Text] [Related]
5. The kinetics of inhibition of type-B monoamine oxidase by clorgyline, pargyline and (-)-deprenyl. Green AL J Pharm Pharmacol; 1981 Dec; 33(12):798-800. PubMed ID: 6121857 [No Abstract] [Full Text] [Related]
6. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Culver KE; Rosenfeld JM; Szechtman H Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768 [TBL] [Abstract][Full Text] [Related]
7. Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A. Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M Eur J Pharmacol; 1996 Oct; 314(1-2):51-9. PubMed ID: 8957218 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine. Grosso DS; Gawienowski AM Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322 [No Abstract] [Full Text] [Related]
11. Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction. Dănilă MD; Privistirescu AI; Mirica SN; Sturza A; Ordodi V; Noveanu L; Duicu OM; Muntean DM Can J Physiol Pharmacol; 2015 Sep; 93(9):819-25. PubMed ID: 26322912 [TBL] [Abstract][Full Text] [Related]
12. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man. Murphy DL; Lipper S; Slater S; Shiling D Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275 [TBL] [Abstract][Full Text] [Related]
13. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation. Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471 [No Abstract] [Full Text] [Related]
14. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects. Murphy DL; Cohen RM; Siever LJ; Roy B; Karoum F; Wyatt RJ; Garrick NA; Linnoila M Mod Probl Pharmacopsychiatry; 1983; 19():287-303. PubMed ID: 6408411 [No Abstract] [Full Text] [Related]
15. Monoamine oxidase-III. Further studies of inhibition by propargylamines. Williams CH; Lawson J Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339 [No Abstract] [Full Text] [Related]
16. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa. Vetulani J; Reichenberg K Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781 [No Abstract] [Full Text] [Related]